-
Palonosetron Hydrochloride in 5-HT3 Research
2026-08-20
Palonosetron hydrochloride combines subnanomolar 5-HT3A and 5-HT3AB inhibition with a prolonged pharmacological profile, making it useful for receptor assays and translational cancer research. A parallel transporter workflow extends its value to OCT2 and MATE1 renal transporter inhibition while preserving clear assay boundaries.
-
HyperFusion™ High-Fidelity DNA Polymerase in C. elegans
2026-08-20
Learn how HyperFusion high-fidelity DNA polymerase can support mechanistic C. elegans neurodegeneration studies, from pheromone-exposure designs to accurate genotyping and amplicon sequencing. This article translates a key Cell Reports study into practical PCR assay decisions without overstating what the biology proves.
-
TRPV1 Modulation in Metastatic Breast Cancer
2026-08-19
This study shows that TRPV1 modulation produces sharply different cytokine responses in immune cells from control mice and mice bearing organ-specific metastatic breast carcinoma. Its unexpected finding that AMG9810 behaved as an inverse agonist highlights how tumor-associated inflammatory context can alter receptor pharmacology and complicate TRPV1-targeted therapy.
-
Sulfo-NHS-SS-Biotin for Cleavable Protein Workflows
2026-08-19
Sulfo-NHS-SS-Biotin combines aqueous, cell-surface-selective labeling with a reducible disulfide spacer for reversible capture and release. This article translates its workflow into practical assays for membrane trafficking, lysosomal exocytosis, affinity purification, and protein analysis.
-
Epalrestat and KEAP1/Nrf2 Neuroprotection in PD
2026-08-18
Jia et al. report that Epalrestat, an established aldose reductase inhibitor, protects dopaminergic neurons in cellular and mouse models of Parkinson’s disease. The study links this effect to direct interaction with KEAP1, activation of Nrf2 signaling, and attenuation of oxidative stress and mitochondrial dysfunction, while remaining preclinical and model-dependent.
-
Annexin V-FITC/PI Apoptosis Assay Kit Guide
2026-08-18
The Annexin V-FITC/PI Apoptosis Assay Kit enables fluorescence-based separation of viable, early apoptotic, and late apoptotic or necrotic cells. Its Annexin V-FITC and PI combination supports early apoptosis detection by flow cytometry or fluorescence microscopy, with a reported 10–20 minute staining workflow.
-
EPZ5676: Mechanism-First DOT1L Translation
2026-08-17
A translational framework for using EPZ5676 to connect SAM-site biochemistry, H3K79 methylation, MLL-rearranged leukemia biology, and carefully bounded epigenetic immunology hypotheses.
-
Annexin V-FITC/PI Apoptosis Assay Kit Guide
2026-08-17
Build a faster, more interpretable apoptosis workflow for toxicology, drug-response, and cell-injury studies. This guide shows how to use dual Annexin V-FITC/PI staining to connect membrane changes with the nickel nanoparticle–lung injury findings reported in recent research.
-
WP1066: JAK2/STAT3 Inhibitor Workflow
2026-08-16
WP1066 is a cell-permeable JAK2/STAT3 inhibitor for dissecting phosphorylation-dependent signaling, cancer cell proliferation, and apoptosis. This workflow also shows how to use it as a pathway perturbation control when studying macrophage metabolism and regenerative scaffolds, without confusing pathway inhibition with scaffold-driven activation.
-
Notch Blockade Sensitizes TNBC to Checkpoint Therapy
2026-08-15
Shen and colleagues show that Notch-driven cytokine programs help triple-negative breast cancer establish an immunosuppressive, macrophage-rich tumor microenvironment. In preclinical models, sequential Notch inhibition followed by immune checkpoint blockade reduced tumor-associated macrophages, increased granzyme B–positive cytotoxic T lymphocytes, and nearly eliminated lung metastases.
-
Z-VEID-FMK: From Caspase-6 to Antiviral Insight
2026-08-14
A translational framework for using Z-VEID-FMK to test caspase-6 dependence in apoptosis and emerging antiviral mechanisms, with a focus on the DDX23–SVA interaction and the controls needed to distinguish causal protease activity from downstream cell death.
-
Nonivamide (Capsaicin Analog) Assay Guide
2026-08-14
This scenario-based guide explains how Nonivamide (Capsaicin Analog), SKU A3278, can support reproducible cell viability, proliferation, and apoptosis workflows. It connects TRPV1 biology with practical solvent handling, orthogonal endpoint selection, and evidence-based vendor evaluation.
-
Hematoxylin and Eosin Staining Kit Guide
2026-08-13
The H&E staining kit provides ready-to-use hematoxylin and eosin solutions for visualizing nuclei, cytoplasm, extracellular matrix, and overall tissue architecture in research samples. It is intended for histological and cytological research, including paraffin-embedded and frozen sections, and must not be used for clinical diagnosis or medical decision-making.
-
PRRSV N Protein, Caspase-6, and IFN Evasion
2026-08-13
The reference study identifies a previously unrecognized PRRSV strategy in which host caspase-6 cleaves the viral N protein at the conserved D94 site, suppressing IRF3 signaling and type I interferon production. Reverse-genetics evidence shows that preventing this cleavage attenuates viral replication and pathogenicity, providing a mechanistic basis for antiviral target discovery and live attenuated vaccine design.
-
Z-VEID-FMK for Caspase-6 Pathway Mapping
2026-08-12
Z-VEID-FMK is a cell-permeable caspase-6 inhibitor for separating protease activity from upstream inflammatory and apoptotic signals. This guide translates recent Homer1a–caspase-6 findings into practical assay design, controls, and interpretation strategies.